Familial progressive supranuclear palsy: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography

Archives of Neurology

Volumn 58, Issue 11, 2001, Pages 1846-1851

  Piccini, Paola ^a   De Yebenez, Justo ^b   Lees, Andrew J ^c   Ceravolo, Roberto ^a   Turjanski, Nora ^a   Pramstaller, Peter ^d   Brooks, David J ^a,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d General Regional Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; AKINESIA; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; DOPAMINERGIC SYSTEM; DYSTONIA; FACIAL NERVE PARALYSIS; FAMILIAL DISEASE; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; METABOLIC DISORDER; OPHTHALMOPLEGIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN;

EID: 0034767781     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.11.1846     Document Type: Article

References (41)

1. Progressive supranuclear palsy
2. Progressive supranuclear palsy
3. Familial progressive supranuclear palsy: Description of a pedigree and review of the literature
4. Clinical genetics of familial progressive supranuclear palsy
5. 18F-dopa positron emission tomography study
6. The role of inheritance in Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins
7. Striatal Dl and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
8. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Oiszewski syndrome): Report of the NINDS-SPSP International Workshop
9. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure and Parkinson's disease, studied with PET
10. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping
11. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease
12. Statistical parametric maps in functional imaging: A general linear approach
13. Physical validation of statistical parametric mapping
14. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
15. 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
16. Positron emission tomography in progressive supranuclear palsy
17. 18F-dopa PET data
18. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy
19. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography
20. Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls
21. Positron emission tomography study in progressive supranuclear palsy: Brain hypometabolic pattern and clinicometabolic correlations
22. Cerebral oxygen metabolism in patients with progressive supranuclear palsy: A positron emission tomography study
23. The "subcortical dementia" of progressive supranuclear palsy
24. Anatomoclinical and biochemical concepts of subcortical dementia
25. Allocortical neurofibrillary changes in progressive supranuclear palsy
26. Neuropathology
27. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy
28. The significance of cortical pathology in progressive supranuclear palsy: Clinico-pathological data in 10 cases
29. The clinical and pathological spectrum of Steel-Richardson-Olszewski syndrome (progressive supranuclear palsy)
30. Clinical and genetic aspects of progressive supranuclear palsy
31. Steele-Richardson-Olszewski disease without ophthalmoplegia: 6 Clinical-anatomic cases
32. Atypical presentation of progressive supranuclear palsy
33. An elderly patient with progressive supranuclear palsy without neurological signs
34. Prevalence and natural history of progressive supranuclear palsy
35. The frequency of idiopathic Parkinson's disease byage, ethnic group, and sex in northern Manhattan, 1988-1993
36. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmstead County, Minnesota, 1976 to 1990
37. Mortality in DATATOP: A multicenter trial in early Parkinson's disease
38. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
39. Natural history of progressive supranuclear palsy and clinical predictors of survival: A clinico-pathological study
40. Progressive supranuclear palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene